<VariationArchive VariationID="224628" VariationName="NM_005461.5(MAFB):c.803del (p.Asn268fs)" VariationType="Deletion" Accession="VCV000224628" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2016-07-20" MostRecentSubmission="2016-09-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="226409" VariationID="224628">
      <GeneList>
        <Gene Symbol="MAFB" FullName="MAF bZIP transcription factor B" GeneID="9935" HGNC_ID="HGNC:6408" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="40685848" stop="40689236" display_start="40685848" display_stop="40689236" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="39314514" stop="39317875" display_start="39314514" display_stop="39317875" Strand="-" />
          </Location>
          <OMIM>608968</OMIM>
          <Haploinsufficiency last_evaluated="2015-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MAFB">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MAFB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005461.5(MAFB):c.803del (p.Asn268fs)</Name>
      <CanonicalSPDI>NC_000020.11:40688047:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="40688048" stop="40688048" display_start="40688048" display_stop="40688048" variantLength="1" positionVCF="40688047" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="39316688" stop="39316688" display_start="39316688" display_stop="39316688" variantLength="1" positionVCF="39316687" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>N268fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.39316689del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.39316689del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.40688049del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.40688049del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023378.1" sequenceAccession="NG_023378" sequenceVersion="1" change="g.6189del">
            <Expression>NG_023378.1:g.6189del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005461.5" sequenceAccession="NM_005461" sequenceVersion="5" change="c.803del" MANESelect="true">
            <Expression>NM_005461.5:c.803del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005452.2" sequenceAccession="NP_005452" sequenceVersion="2" change="p.Asn268fs">
            <Expression>NP_005452.2:p.Asn268fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10575959" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608968.0007" DB="OMIM" />
        <XRef Type="rs" ID="879255275" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005461.5(MAFB):c.803del (p.Asn268fs) AND multiple conditions" Accession="RCV000240679" Version="2">
        <ClassifiedConditionList TraitSetID="25687">
          <ClassifiedCondition DB="MedGen" ID="C0751083">Duane retraction syndrome 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0994516">Duane syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005461.5(MAFB):c.803del (p.Asn268fs) AND Duane retraction syndrome 3 with or without deafness" Accession="RCV000235061" Version="1">
        <ClassifiedConditionList TraitSetID="31282">
          <ClassifiedCondition DB="MedGen" ID="C4310752">Duane retraction syndrome 3 with or without deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-07-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-03-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-07-20" MostRecentSubmission="2016-09-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27181683</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25687" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1501" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duane syndrome type 1</ElementValue>
                <XRef ID="Duane+Retraction+Syndrome+1/2334" DB="Genetic Alliance" />
                <XRef ID="MONDO:0024265" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DURS1</ElementValue>
                <XRef Type="MIM" ID="126800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10763" />
                <XRef ID="10763" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Duane syndrome is a strabismus condition clinically characterized by congenital non-progressive limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure. The lateral movement anomaly results from failure of the abducens nucleus and nerve (cranial nerve VI) to fully innervate the lateral rectus muscle; globe retraction occurs as a result of abnormal innervation of the lateral rectus muscle by the oculomotor nerve (cranial nerve III). At birth, affected infants have restricted ability to move the affected eye(s) outward (abduction) and/or inward (adduction), though the limitations may not be recognized in early infancy. In addition, the globe retracts into the orbit with attempted adduction, accompanied by narrowing of the palpebral fissure. Many individuals with Duane syndrome have strabismus in primary gaze but can use a compensatory head turn to align the eyes, and thus can preserve binocular vision and avoid diplopia. Individuals with Duane syndrome who lack binocular vision are at risk for amblyopia. The majority of affected individuals with Duane syndrome have isolated Duane syndrome (i.e., they do not have other detected congenital anomalies). Other individuals with Duane syndrome fall into well-defined syndromic diagnoses. However, many individuals with Duane syndrome have non-ocular findings that do not fit a known syndrome; these individuals are included as part of the discussion of nonsyndromic Duane syndrome.</Attribute>
                <XRef ID="NBK1190" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301369</ID>
                <ID Source="BookShelf">NBK1190</ID>
              </Citation>
              <XRef ID="233" DB="Orphanet" />
              <XRef ID="C0994516" DB="MedGen" />
              <XRef ID="MONDO:0024265" DB="MONDO" />
              <XRef Type="MIM" ID="126800" DB="OMIM" />
            </Trait>
            <Trait ID="1988" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duane retraction syndrome 2</ElementValue>
                <XRef ID="MONDO:0011444" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duane syndrome type 2</ElementValue>
                <XRef ID="Duane+Retraction+Syndrome+2/2335" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DURS2</ElementValue>
                <XRef Type="MIM" ID="604356" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Duane syndrome is a strabismus condition clinically characterized by congenital non-progressive limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure. The lateral movement anomaly results from failure of the abducens nucleus and nerve (cranial nerve VI) to fully innervate the lateral rectus muscle; globe retraction occurs as a result of abnormal innervation of the lateral rectus muscle by the oculomotor nerve (cranial nerve III). At birth, affected infants have restricted ability to move the affected eye(s) outward (abduction) and/or inward (adduction), though the limitations may not be recognized in early infancy. In addition, the globe retracts into the orbit with attempted adduction, accompanied by narrowing of the palpebral fissure. Many individuals with Duane syndrome have strabismus in primary gaze but can use a compensatory head turn to align the eyes, and thus can preserve binocular vision and avoid diplopia. Individuals with Duane syndrome who lack binocular vision are at risk for amblyopia. The majority of affected individuals with Duane syndrome have isolated Duane syndrome (i.e., they do not have other detected congenital anomalies). Other individuals with Duane syndrome fall into well-defined syndromic diagnoses. However, many individuals with Duane syndrome have non-ocular findings that do not fit a known syndrome; these individuals are included as part of the discussion of nonsyndromic Duane syndrome.</Attribute>
                <XRef ID="NBK1190" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9966" />
                <XRef ID="9966" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301369</ID>
                <ID Source="BookShelf">NBK1190</ID>
              </Citation>
              <XRef ID="233" DB="Orphanet" />
              <XRef ID="C0751083" DB="MedGen" />
              <XRef ID="MONDO:0011444" DB="MONDO" />
              <XRef Type="MIM" ID="604356" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31282" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="35763" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Duane syndrome type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duane retraction syndrome 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Duane retraction syndrome 3 with or without deafness</ElementValue>
                <XRef ID="MONDO:0014880" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DURS3</ElementValue>
                <XRef Type="MIM" ID="617041" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10691" />
                <XRef ID="10691" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Duane syndrome is a strabismus condition clinically characterized by congenital non-progressive limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure. The lateral movement anomaly results from failure of the abducens nucleus and nerve (cranial nerve VI) to fully innervate the lateral rectus muscle; globe retraction occurs as a result of abnormal innervation of the lateral rectus muscle by the oculomotor nerve (cranial nerve III). At birth, affected infants have restricted ability to move the affected eye(s) outward (abduction) and/or inward (adduction), though the limitations may not be recognized in early infancy. In addition, the globe retracts into the orbit with attempted adduction, accompanied by narrowing of the palpebral fissure. Many individuals with Duane syndrome have strabismus in primary gaze but can use a compensatory head turn to align the eyes, and thus can preserve binocular vision and avoid diplopia. Individuals with Duane syndrome who lack binocular vision are at risk for amblyopia. The majority of affected individuals with Duane syndrome have isolated Duane syndrome (i.e., they do not have other detected congenital anomalies). Other individuals with Duane syndrome fall into well-defined syndromic diagnoses. However, many individuals with Duane syndrome have non-ocular findings that do not fit a known syndrome; these individuals are included as part of the discussion of nonsyndromic Duane syndrome.</Attribute>
                <XRef ID="NBK1190" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301369</ID>
                <ID Source="BookShelf">NBK1190</ID>
              </Citation>
              <XRef ID="233" DB="Orphanet" />
              <XRef ID="C4310752" DB="MedGen" />
              <XRef ID="MONDO:0014880" DB="MONDO" />
              <XRef Type="MIM" ID="617041" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="498734" SubmissionDate="2016-03-11" DateLastUpdated="2016-09-14" DateCreated="2016-09-14">
        <ClinVarSubmissionID localKey="c.803delA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000265997" DateUpdated="2016-09-14" DateCreated="2016-09-14" Type="SCV" Version="3" SubmitterName="Engle Laboratory, Boston Children's Hospital" OrgID="18646" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">27181683</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">27181683</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Bi-directional Sanger Sequence Analysis</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Genewiz</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <CellLine>HEK 293T; lymphoblastoid</CellLine>
              <Species TaxonomyId="9606">Human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <Description>Transcriptional activation assay (luciferase)</Description>
              <MethodType>research</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">Dominant negative</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Comment>Pathogenicity supported by mouse in vivo data</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAFB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005461.4:c.803delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="126800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604356" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">27181683</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27181683</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="557953" SubmissionDate="2016-07-18" DateLastUpdated="2016-07-20" DateCreated="2016-07-20">
        <ClinVarSubmissionID localKey="608968.0007_DUANE RETRACTION SYNDROME 3 WITH DEAFNESS" title="MAFB, 1-BP DEL, 803A_DUANE RETRACTION SYNDROME 3 WITH DEAFNESS" />
        <ClinVarAccession Accession="SCV000292425" DateUpdated="2016-07-20" DateCreated="2016-07-20" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected members of a family (family FA) with Duane retraction syndrome and hearing loss (DURS3; 617041), Park et al. (2016) identified heterozygosity for a 1-bp deletion (c.803delA, NM_005461.4) within the LZ of the MAFB gene, causing a frameshift predicted to result in premature termination codon (Asn268MetfsTer125), with retention of the EHR and BR domains in the mutant protein. Functional analysis by luciferase assay in transfected HEK293T cells showed no activity with the mutant protein alone, and reduced transcriptional activity of wildtype MAFB when coexpressed with the mutant, consistent with a dominant-negative mechanism. Affected members of this family exhibited phenotypic variability, having either type 1 or type 3 DURS, which was unilateral and right-sided in the mother and 2 affected sons, and bilateral in the affected granddaughter. The mother and 1 son also had right-sided deafness, whereas the granddaughter had bilateral deafness; her affected father did not report deafness, but had not undergone formal hearing testing.</Attribute>
              <Citation>
                <ID Source="PubMed">27181683</ID>
              </Citation>
              <XRef DB="OMIM" ID="617041" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAFB" />
          </GeneList>
          <Name>MAFB, 1-BP DEL, 803A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 803A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608968.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DUANE RETRACTION SYNDROME 3 WITH DEAFNESS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="498734" TraitType="Disease" MappingType="XRef" MappingValue="604356" MappingRef="OMIM">
        <MedGen CUI="C0751083" Name="Duane retraction syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="498734" TraitType="Disease" MappingType="XRef" MappingValue="126800" MappingRef="OMIM">
        <MedGen CUI="C0994516" Name="Duane syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

